Live Breaking News & Updates on Beta Hexoseaminidase

Stay updated with breaking news from Beta hexoseaminidase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Taysha Gene Therapies : Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Positive pre-IND/CTA feedback obtained from several key regulatory agencies for TSHA-102 in Rett syndrome, TSHA-101 in GM2 gangliosidosis and TSHA-118 in CLN1 disease, paving the way for multiple. | August 17, 2021 ....

United States , Omary Newman , Beta Hexoseaminidase , Silicon Valley Bank , Rare Disease Company Coalition , Queen University , Us National Institutes Of Health , Exchange Commission , Development Rd Expenses , Taysha Gene Therapies Inc , Regulatory Affairs At Astellas Gene Therapies , Ut Southwestern Gene Therapy Program , Taysha Gene Therapies , Intramural Program , National Institute , Neurological Disorders , Principal Investigator , Chief Development Officer , Senior Vice President , Regulatory Affairs , Astellas Gene Therapies , Investigational New Drug , Investor Day , Gene Therapies , Gene Therapy Program , Private Securities Litigation Reform Act ,